- Diagnostics
- Tuesday, 04 Feb 2020
U.S. health experts will now Aid China to Fight the Fast-Spreading Coronavirus
China has agreed to allow U.S. health experts into the country as part of a World Health Organization (WHO) effort to help fight the fast-spreading coronavirus, as the number of cases and deaths continued to mount.
In central China’s Hubei province, epicenter of the epidemic, China state TV reported there were 2,345 new cases of the virus and another 64 deaths, bringing the total of virus-related fatalities in Hubei to 414 by Monday.
The Chinese stock market plunged about 8% on Monday, wiping $393 billion off the value of the Shanghai bourse, on the first day of trading following an extended Lunar New Year holiday in a bid to help keep people at home and contain the virus’ spread.
The White House said on Monday China had accepted its offer to have U.S. experts as part of a WHO mission to study and help combat the virus that emerged in Hubei’s provincial capital of Wuhan.
A 1,000-bed hospital built in eight days to treat people with the virus in Wuhan was due to receive its first patients on Monday, state media said. A second hospital with 1,600 beds is due to be operational later this week.
With Wuhan and some other Chinese cities in virtual lockdown, travel severely restricted and China facing increasing international isolation, fears of wider economic disruption are growing. Sources at the OPEC oil cartel told Reuters producers were considering cutting output by almost a third to support prices.
The WHO last week declared the flu-like virus a global emergency. It has spread to 23 other countries and regions. The Philippines reported the first coronavirus death outside of China.
Airlines around the world have stopped flights to parts of China. A suspension by the United Arab Emirates on Monday will affect the Gulf airlines Etihad and Emirates.
Earlier on Monday, China accused the United States of spreading fear by pulling its citizens out and severely restricting travel.
Related Industry Updates
Viracor Eurofins Launches Highly Accurate Antibody Tests for Coronavirus (COVID-19) SARS-CoV-2
May 08, 2020
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features
Nov 11, 2019
QIAGEN Launched QIAstat-Dx for Transplant Diagnostics in Europe
Sep 12, 2019
ZEUS Scientific Announces New Rapid SARS-CoV-2 Antibody Test
Apr 23, 2020
OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
Apr 30, 2020
Allergy Diagnostics Market - SWOT Analysis of Major Industry Segments
Dec 19, 2020
Indian Patients to Get Face-to-face Consultations for Coronavirus-2019
Feb 25, 2020